OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

QIAGEN NV EO -,01/  NL0015001WM6  /

Stuttgart
2024-05-24  9:59:02 PM Chg. +0.395 Volume Bid10:00:02 PM Ask10:00:02 PM Market Capitalization Dividend Y. P/E Ratio
40.180EUR +0.99% 270
Turnover: 10,832.550		 -Bid Size: - -Ask Size: - 9.18 bill.EUR - -
GlobeNewswire 05-22 deepull appoints Didier Deltort to its Board of Directors
GlobeNewswire 05-14 QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical devic...
GlobeNewswire 05-13 QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accura...
GlobeNewswire 05-07 QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
GlobeNewswire 05-07 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 05-07 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 05-02 QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inher...
GlobeNewswire 04-29 QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
GlobeNewswire 04-25 deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ...
GlobeNewswire 04-24 QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and comba...
GlobeNewswire 04-18 deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing...
GlobeNewswire 04-09 QIAGEN N.V. to release results for Q1 2024 and hold webcast
GlobeNewswire 04-03 QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Ann...
GlobeNewswire 03-25 QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration a...
GlobeNewswire 03-18 QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosi...
GlobeNewswire 03-11 QIAGEN announces Form 20-F annual report filing for 2023 results
GlobeNewswire 02-27 QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
GlobeNewswire 02-27 QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
GlobeNewswire 02-15 QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
GlobeNewswire 02-06 QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved op...
TeleTrader 02-06 Europe higher at close, economic prints in spotlight
TeleTrader 01-29 Europe opens mixed ahead of data
GlobeNewswire 01-25 QIAGEN announces partnership with Penn State University to advance microbiome sciences
GlobeNewswire 01-18 QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 mi...
GlobeNewswire 01-11 QIAGEN N.V. to release results for Q4 2023 and hold webcast